Free tool
FAERS Monitor: Cellcept
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050758 or its brand name (Cellcept, Mycophenolate Mofetil Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
138,802
Serious
126,629
91% of reports
Hospitalization
53,415
Death reported
24,926
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use20,344
- drug ineffective11,621
- product use in unapproved indication7,426
- diarrhoea7,211
- pyrexia5,839
- pneumonia5,519
- cytomegalovirus infection5,007
- fatigue4,809
- nausea4,737
- condition aggravated4,653
- dyspnoea4,390
- vomiting4,236
- transplant rejection4,170
- headache4,154
- infection4,015
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 773 |
| 2005 | 865 |
| 2006 | 1,201 |
| 2007 | 1,359 |
| 2008 | 1,722 |
| 2009 | 2,396 |
| 2010 | 2,298 |
| 2011 | 2,496 |
| 2012 | 2,714 |
| 2013 | 2,861 |
| 2014 | 3,111 |
| 2015 | 3,703 |
| 2016 | 4,508 |
| 2017 | 7,331 |
| 2018 | 8,478 |
| 2019 | 10,703 |
| 2020 | 11,592 |
| 2021 | 10,644 |
| 2022 | 10,127 |
| 2023 | 11,130 |
| 2024 | 14,284 |
| 2025 | 14,302 |
| 2026 | 10,195 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,915,357 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| transplant rejectionSignal | 4,170 | 163.1 | 156.2 | 322,684 |
| cytomegalovirus infectionSignal | 5,007 | 64.9 | 62.8 | 220,248 |
| product use in unapproved indicationSignal | 7,426 | 4.6 | 4.5 | 20,879 |
| infectionSignal | 4,015 | 4.3 | 4.2 | 9,933 |
| off label useSignal | 20,344 | 3.6 | 3.5 | 38,560 |
| pneumoniaSignal | 5,519 | 2.6 | 2.5 | 5,473 |
| pyrexiaSignal | 5,839 | 2.6 | 2.5 | 5,665 |
| condition aggravatedSignal | 4,653 | 2.3 | 2.3 | 3,564 |
| diarrhoea | 7,211 | 1.7 | 1.7 | 2,123 |
| vomiting | 4,236 | 1.4 | 1.3 | 426 |
| drug ineffective | 11,621 | 1.3 | 1.3 | 1,055 |
| dyspnoea | 4,390 | 1.2 | 1.1 | 118 |
| headache | 4,154 | 1.0 | 1.0 | 0 |
| fatigue | 4,809 | 0.9 | 0.9 | 22 |
| nausea | 4,737 | 0.9 | 0.9 | 47 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.